← All decks

General Surgery

Cancers of the Periampullary Region and the Pancreas

Built from Maingot's Abdominal Operations

What’s inside

22 sections · 160 slides

  1. 01

    Overview

    • Scope of this presentation

    1 slide

  2. 02

    What periampullary cancer means

    Four tumours, one small piece of anatomy

    • Definition of periampullary cancer
    • Rationale for grouping the four cancers
    • Anatomical origins of periampullary cancer
    • Early attempts at resection
    • Establishment of pancreaticoduodenectomy
    • ~2%

    6 slides

  3. 03

    Incidence and epidemiology

    How common, where, and in whom

    • Burden of pancreatic cancer in the United States
    • Geographic trends and demographic distribution

    2 slides

  4. 04

    Pathology

    What the tumours are made of

    • Adenocarcinoma as the dominant histology
    • Site of origin of periampullary adenocarcinoma
    • Uncommon tumours of the periampullary region
    • Distribution of pancreatic ductal adenocarcinoma
    • Pancreatic endocrine and cystic neoplasms

    5 slides

  5. 05

    Risk factors

    What is proven, what is weak, what is myth

    • Established and weak environmental risk factors
    • Evidence linking cigarette smoking to pancreatic cancer
    • Dietary associations
    • Exposures with little or no established risk
    • Chronic pancreatitis and diabetes as risk factors
    • Risk factors for the non-pancreatic periampullary cancers
    • Hereditary syndromes predisposing to pancreatic cancer
    • Familial pancreatic cancer and polyposis syndromes

    8 slides

  6. 06

    Genetic alterations

    What sequencing the tumour genome showed

    • Genomic tools applied to cancer
    • The pancreatic cancer genome project
    • Frequency of the commonest gene alterations
    • Genetics of ampullary adenocarcinoma

    4 slides

  7. 07

    Clinical presentation

    Symptoms, signs and laboratory findings

    • Aim of the workup and timing of symptoms
    • Symptoms of obstructive jaundice
    • Mechanism of obstructive jaundice
    • Pain and gastric outlet obstruction
    • Subtle presentations and presentation by site
    • Physical findings on examination
    • Physical signs of advanced disease
    • Laboratory findings in biliary obstruction
    • CA 19-9 and molecular markers

    9 slides

  8. 08

    Imaging studies

    Choosing the test that answers the question

    • Imaging modalities and the shift to noninvasive tests
    • Choosing an imaging test
    • Role of right upper quadrant ultrasonography
    • Multidetector spiral CT in diagnosis and staging
    • Dilated intrahepatic bile ducts on CT
    • Double-duct sign on CT
    • Pancreatic mass lying against the superior mesenteric artery
    • Three-dimensional CT vascular reconstruction
    • Portal and superior mesenteric veins on three-dimensional CT
    • Superior mesenteric artery on three-dimensional CT
    • Magnetic resonance imaging and cholangiopancreatography
    • Hypodense pancreatic head mass on contrast-enhanced MRI
    • Dilated bile and pancreatic ducts on magnetic resonance cholangiopancreatography
    • Endoscopic retrograde cholangiopancreatography
    • Indications for ERCP in periampullary cancer
    • Pancreatic and bile duct obstruction on ERCP
    • Completion cholangiogram after endoscopic stenting
    • Percutaneous cholangiography and positron emission tomography
    • Complete obstruction of the common bile duct on percutaneous cholangiography
    • Upper endoscopy and endoscopic ultrasound
    • Pancreatic head mass without vascular invasion on endoscopic ultrasound

    21 slides

  9. 09

    Tissue diagnosis

    When a biopsy changes the plan and when it does not

    • Tissue diagnosis before curative resection
    • Situations that do require tissue before treatment
    • Safety and yield of biopsy by site

    3 slides

  10. 10

    Preoperative biliary decompression

    Should the duct be drained before operating

    • Indications for preoperative biliary decompression
    • Evidence on preoperative biliary stenting

    2 slides

  11. 11

    Preoperative staging

    Deciding who should go to the operating room

    • Purpose and limits of staging imaging
    • Accuracy of three-dimensional CT in predicting resectability
    • Radiological signs of unresectability
    • Arguments for and against routine staging laparoscopy
    • Selective use of endoscopic ultrasound and laparoscopy
    • Clinicopathologic staging systems

    6 slides

  12. 12

    Pancreaticoduodenectomy

    The Whipple procedure, step by step

    • Sequence of pancreaticoduodenectomy
    • Incision, exposure and assessment of resectability
    • The Kocher maneuver
    • Bimanual palpation of the uncinate process
    • Relation of the uncinate process to the mesenteric vessels
    • Order of dissection and division of the bile duct
    • Gastroduodenal artery clamp test and division of the jejunum
    • Classic Whipple and pylorus-preserving variants
    • Exposure of the superior mesenteric vein
    • Developing the retropancreatic tunnel
    • Division of the pancreatic neck
    • Dissection of the uncinate process
    • Marking the resection margins
    • Order of reconstruction
    • Standard reconstruction after pancreaticoduodenectomy
    • Options for pancreatic reconstruction
    • Pancreaticogastrostomy reconstruction
    • Controversies in pancreatic reconstruction
    • Duct-to-mucosa anastomosis and duct stents
    • Invagination technique and pancreaticogastrostomy
    • Biliary and gastric anastomoses
    • Drains and postoperative management

    22 slides

  13. 13

    Distal pancreatectomy

    For cancer of the body or tail

    • Role of splenectomy with distal pancreatectomy
    • Exposure and entry into the lesser sac
    • Exposure of the pancreatic body and tail
    • Control of the splenic artery and vein
    • Transection of the pancreas and fistula prevention
    • Cancer of the body of the pancreas

    6 slides

  14. 14

    Operative palliation

    When cure is impossible but the abdomen is already open

    • Indications for operative palliation
    • The three problems palliation must solve
    • Operative palliation of obstructive jaundice
    • Technique of palliative hepaticojejunostomy
    • Anatomy after palliative bypass
    • Prophylactic gastrojejunostomy for duodenal obstruction
    • Technique of palliative gastrojejunostomy
    • Operative chemical splanchnicectomy for pain
    • Technique of alcohol celiac plexus block

    9 slides

  15. 15

    Nonoperative palliation

    Stents, blocks and analgesia

    • Proportion suitable for cure and routes of biliary drainage
    • Plastic and self-expanding metallic biliary stents
    • Selecting a stent and treating duodenal obstruction
    • Distal bile duct obstruction treated by metal stenting
    • Nonoperative palliation of pain

    5 slides

  16. 16

    Complications of resection

    What goes wrong and how often

    • 1.4%
    • Commonest complications after pancreaticoduodenectomy
    • Delayed gastric emptying
    • Postoperative pancreatic fistula
    • Complications after distal pancreatectomy

    5 slides

  17. 17

    Long-term survival

    What resection actually achieves

    • Composition of a resected periampullary series
    • Five-year survival by site of origin
    • Interpretation of survival and features of five-year survivors
    • Survival after resection of pancreatic cancer by tumour location
    • Survival by resection margin and lymph node status
    • Survival by tumour size and differentiation
    • Survival after 1423 pancreaticoduodenectomies
    • Prognostic factors in resected pancreatic cancer
    • Survival after resection of ampullary adenocarcinoma
    • Molecular prognosis and hospital volume

    10 slides

  18. 18

    Adjuvant therapy

    Treatment given after resection

    • Current state of adjuvant therapy
    • The GITSG adjuvant trial
    • Multiagent regimens and the gemcitabine comparison
    • The ESPAC-1 trial
    • The CONKO-001 trial
    • Survival with and without postoperative chemoradiation
    • Adjuvant therapy for non-pancreatic periampullary cancers

    7 slides

  19. 19

    Neoadjuvant therapy

    Treatment given before resection

    • Theoretical advantages of neoadjuvant therapy
    • The Duke University neoadjuvant series
    • The M.D. Anderson neoadjuvant programme
    • Preoperative chemoradiation trials for resectable pancreatic cancer
    • Preoperative chemoradiation trials at a single cancer centre
    • Reading the neoadjuvant trial results

    6 slides

  20. 20

    Novel agents in pancreatic cancer

    Targeting the molecular defects

    • Rationale for targeted agents
    • Basis and attractions of immune-based therapy
    • Phase I trial of a GM-CSF-secreting tumour vaccine
    • Bevacizumab in advanced pancreatic cancer
    • K-ras and farnesyltransferase inhibition
    • The epidermal growth factor receptor family
    • Trastuzumab in Her-2-positive pancreatic cancer
    • Erlotinib combined with gemcitabine

    8 slides

  21. 21

    Conclusion

    What to carry away

    • Summary of management principles
    • 15-20%
    • Pathway from presentation to treatment

    3 slides

  22. 22

    References

    Sources cited in this topic

    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    12 slides